Anaphylaxis following the use of a plasma-derived immunopurified monoclate-P, and the recombinant Recombinate and Kogenate factor VIII: a therapeutic challenge.

Source:http://linkedlifedata.com/resource/pubmed/id/10215966

Download in:

View as

General Info

PMID
10215966